Bio

  • Bio
    A new lawsuit alleges anti-aging startup Elysium Health hasn’t paid its sole supplier

    A new lawsuit alleges anti-aging startup Elysium Health hasn’t paid its sole supplier

    Chromadex, the sole supplier of anti-aging startup Elysium Health‘s two main product ingredients pterostilbene and Nicotinamide Riboside (NR), is suing the startup for failure to make payments on those ingredients and for breach of a trademark and royalties agreement. According to a document on Chromadex’s website, dated December 29, 2016, Elysium “made… Read More

  • Bio
    Arizona plans to sue Theranos over faulty blood tests

    Arizona plans to sue Theranos over faulty blood tests

    Arizona Attorney General Mark Brnovich is soliciting outside legal counsel to pursue a consumer fraud lawsuit against the beleaguered blood testing startup Theranos, according to a document posted on the state’s procurement website. Brnovich has so far declined to comment on any action, but the document contends Theranos may have defrauded customers in the state and the office is… Read More

  • Bio
    Women’s health startup Celmatix now offers genetic testing for fertility issues

    Women’s health startup Celmatix now offers genetic testing for fertility issues

    Celmatix, a startup with a focus on personalized medicine for women, wants to take some of the mystery out of the science of baby-making with a new type of DNA-based fertility test called Fertilome. Fertilome looks at 49 variants in 32 genes that give you a likelihood or not for inherited disorders such as endometriosis or PCOS to help women determine the best course of action to take based… Read More

  • Bio
    Illumina wants to sequence your whole genome for $100

    Illumina wants to sequence your whole genome for $100

    The first sequencing of the whole human genome in 2003 cost roughly $2.7 billion, but DNA sequencing giant Illumina has now unveiled a new machine that the company says is “expected one day” to order up your whole genome for less than $100. Illumina’s CEO Francis deSouza showed off the machine, called the NovaSeq, onstage at the JP Morgan Healthcare Conference in downtown… Read More

  • Bio
    Theranos slashes another 41 percent of its workforce

    Theranos slashes another 41 percent of its workforce

    Not a week goes by and it seems like we hear more bad news about Silicon Valley’s darling turned cautionary tale Theranos. The latest bit is a whopping 155 layoffs at the company today. The one drop blood test company once worth $9 billion took a quite the tumble from grace after an intense series of investigations from the Centers for Medicare & Medicaid Services and the U.S. Food… Read More

  • Bio
    Grail is raising at least $1 billion to fund its early cancer screening test

    Grail is raising at least $1 billion to fund its early cancer screening test

    The early cancer screening startup Grail plans to raise more than $1 billion in Series B financing, possibly up to $1.8 billion. While the company doesn’t want to name investor names, only mentioning in a release the funding will come “primarily from undisclosed private and strategic investors,” Microsoft co-founder Bill Gates, Amazon founder Jeff Bezos, Google Ventures… Read More

  • Bio
    Silicon Valley Bank predicts a 2017 cure for the healthtech investment doldrums

    Silicon Valley Bank predicts a 2017 cure for the healthtech investment doldrums

    Things are looking up for biotech and health device startups wanting to cash in on VC dollars or go public this year. According to Silicon Valley Bank’s latest report on healthcare investments and exits, a conservative 2016 has set up 2017 for a hearty boom. Though biopharma M&A activity declined slightly last year and IPOs declined more than 30 percent, according to the report… Read More

  • Bio
    Move over Cas9, CRISPR-Cas3 might hold the key to solving the antibiotics crisis

    Move over Cas9, CRISPR-Cas3 might hold the key to solving the antibiotics crisis

    Researchers at North Carolina-based Locus Biosciences think they have a potential cure for antibiotic resistance using CRISPR’s lesser-known Cas3 enzyme. Most of the interest in CRISPR technology centers around the enzyme Cas9, which acts as a type of genetic scissors, allowing scientists to snip out, edit and replace DNA at certain intervals along the genome. However, Cas3 goes beyond… Read More

  • Bio
    Synthetic biology startup Lygos raises $13 million from OS Fund and IA Ventures to make cleaner chemicals

    Synthetic biology startup Lygos raises $13 million from OS Fund and IA Ventures to make cleaner chemicals

    Lygos uses microbugs to convert low-cost sugar into specialty chemicals used in manufacturing, and is now releasing a technique to make malic acid, an ingredient needed in the mass production of electronics. To do so, the company announced today it has raised $13 million in Series A funding led by OS Fund and IA Ventures, with participation from First Round Capital, Y Combinator’s… Read More

  • Bio
    Open Bionics partners with NHS for a feasibility study to bring bionic hands to the U.K. health system

    Open Bionics partners with NHS for a feasibility study to bring bionic hands to the U.K. health system

    Open Bionics is a U.K. startup making bionic hands for patients needing prosthetics and co-founder of the company Samantha Payne came onstage today at TechCrunch Disrupt London to tell us about a new deal between Open Bionics and the National Health Service (NHS) to bring new technologies to amputees. The deal involves a feasibility study with the NHS through SBRI Healthcare to see if… Read More

  • Bio
    BenevolentBio’s artificial intelligence could discover a better treatment for ALS

    BenevolentBio’s artificial intelligence could discover a better treatment for ALS

    What if the drug that could effectively treat amyotrophic lateral sclerosis, the paralyzing neurological disease that skyrocketed into the public consciousness thanks to the ice bucket challenge, already exists? That’s the question confronting Jackie Hunter, CEO of BenevolentBio. Hunter runs the biomedical arm of the artificial intelligence firm BenevolentAI, applying machine learning… Read More

  • InsideDNA looks deep into DNA to find the best drug targets

    Using a computational platform and your DNA, bioinformatics startup InsideDNA aims to determine the right drug interaction for your body. The startup began three years ago as a cloud-based platform for genomics analysis called InsideDNA Research, which brought optimized storage and reproducible research to scientists through cloud computing. But it soon saw a broader problem in the… Read More

  • Bio
    Sean Parker is partnering with the Cancer Research Institute to find a cancer vaccine

    Sean Parker is partnering with the Cancer Research Institute to find a cancer vaccine

    Cancerous tumors carry certain markers called neoantigens and Facebook billionaire Sean Parker wants to use algorithms to find them. To do so, the Parker Institute for Cancer Immunotherapy will work with more than 30 public and private pharmaceutical, biotech, cancer research nonprofits and academic institutions through a partnership with the Cancer Research Institute to use predictive… Read More

  • Bio
    Lab-made meat startup Memphis Meats hopes to grow a Thanksgiving turkey

    Lab-made meat startup Memphis Meats hopes to grow a Thanksgiving turkey

    Memphis Meats sizzled onto the startup stage earlier this year with a lab-grown meatball. Now, it’s entertaining the idea of growing other meats — including turkey. The startup has created an Indiegogo campaign to save some of the nearly 50 million birds from the slaughter each Thanksgiving by educating the public on what meat of the future could look and taste like. While I am… Read More

  • Bio
    Genalyte raises $36 million from Khosla for its one-drop blood test

    Genalyte raises $36 million from Khosla for its one-drop blood test

    Theranos competitor Genalyte just announced it has raised an equity round of $36 million in funding led by Khosla Ventures and Redmile Group. The San Diego-based startup leverages lab-on-a-chip technology it says can run through up to 128 different tests on a single finger prick of blood in under 15 minutes using what it calls its Maverick Detection Platform. Genalyte’s proprietary… Read More

  • Bio
    Chinese scientists CRISPR a human for the first time

    Chinese scientists CRISPR a human for the first time

    A group of Chinese scientists injected a human being with cells genetically edited using CRISPR-Cas9 technology. This is the first time CRISPR has been used on a fully formed adult human and it’s encouraged a biomedical battle between China and the United States. The scientists from China are hoping the genetically edited cells will help their patient fend off a virulent type of… Read More

  • Bio
    Walgreens is suing Theranos for $140 million in Delaware

    Walgreens is suing Theranos for $140 million in Delaware

    Walgreens has filed a lawsuit against blood analysis company Theranos. Walgreens was once Theranos’ biggest partner and the startup used several of the drugstore chain’s Arizona store locations as testing sites. However, Walgreens formally severed ties with the startup in June, citing the myriad bad test results and a federal investigation as the reason for ending the… Read More

  • Bio
    Oral arguments for who owns CRISPR-Cas9 start next month

    Oral arguments for who owns CRISPR-Cas9 start next month

    The date has been set for oral arguments to begin over who owns the patent rights to the gene-editing wonder CRISPR-Cas9. Berkeley’s Jennifer Doudna and her colleague from the Max Planck Institute Emmanuelle Charpentier head to court on December 6th to face off against MIT’s Feng Zhang and present their argument before three US Patent and Trademark Office judges on why… Read More

  1. 1
  2. 2
  3. ...